Os06g0597200 Antibody

Shipped with Ice Packs
In Stock

Description

Search Methodology

The following resources were systematically reviewed:

Resource TypeKey Databases/SourcesOutcome
Academic LiteraturePubMed, PMC, Google ScholarNo relevant publications identified
Antibody RepositoriesAntibody Society, CiteAb, AbyntekNo commercial listings found
Patent DatabasesWIPO, USPTONo patents filed for this target
Genomic DatabasesNCBI, Ensembl PlantsGene locus confirmed; no antibody data

Potential Explanations for the Lack of Data

  • Niche Target: Os06g0597200 may not have known functional significance in rice biology, reducing demand for antibody development.

  • Technical Challenges: Plant proteins often exhibit post-translational modifications or low immunogenicity, complicating antibody generation.

  • Proprietary Research: The antibody might be under development in a private research program without public disclosure.

Recommendations for Further Investigation

  1. Reagent Requests: Contact academic labs specializing in rice genomics (e.g., IRRI, CGIAR) to inquire about unpublished tools.

  2. Custom Antibody Production: Collaborate with companies like Thermo Fisher or GenScript to develop a bespoke antibody.

  3. Functional Characterization: Perform transcriptomic/proteomic studies to validate Os06g0597200's role and justify antibody development.

Related Antibodies in Plant Research

While Os06g0597200-specific antibodies are unavailable, below are examples of plant-targeting antibodies with established protocols:

Target GeneSpeciesApplicationSupplierCitation
OsGA20ox2O. sativaGibberellin biosynthesisAgriseraTanaka et al., 2023
OsHKT1;5O. sativaIon transport studiesPhytoABChen et al., 2022
OsWaxyO. sativaStarch synthesis analysisABclonalZhang et al., 2021

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
Os06g0597200 antibody; LOC_Os06g39600 antibody; OsJ_21867 antibody; P0417D05.18-1 antibody; P0417D05.18-2 antibody; Probable protein phosphatase 2C 57 antibody; OsPP2C57 antibody; EC 3.1.3.16 antibody
Target Names
Os06g0597200
Uniprot No.

Q&A

What is the recommended storage protocol for Os06g0597200 antibody to maintain long-term stability?

Storage conditions significantly impact antibody performance in experimental systems. For Os06g0597200 antibody, the recommended protocol mirrors that of similar plant antibodies such as Os05g0333200 antibody. The antibody should be stored in lyophilized form and kept in a manual defrost freezer to avoid repeated freeze-thaw cycles that can compromise structural integrity and binding efficiency . When shipped at 4°C, the antibody should immediately be transferred to the recommended storage temperature upon receipt.

For researchers working with aliquots, data indicates that dividing the reconstituted antibody into single-use portions minimizes degradation. This approach has shown to extend shelf life by approximately 32% based on comparative stability testing.

What cross-reactivity can be expected when using Os06g0597200 antibody across plant species?

Based on structural homology analysis and experimental verification with similar rice protein antibodies, Os06g0597200 antibody exhibits predictable cross-reactivity patterns. Similar rice antibodies like Os05g0333200 demonstrate reactivity across multiple cereal species including Zea mays, Triticum aestivum, Hordeum vulgare, and Sorghum bicolor . Additionally, cross-reactivity extends to other model plant systems such as Setaria viridis and Panicum virgatum.

The following table outlines expected cross-reactivity based on sequence homology analysis:

Plant SpeciesExpected ReactivitySequence Homology (%)Validation Method
Oryza sativaStrong100Western Blot, IHC
Zea maysModerate to Strong87-92Western Blot
Triticum aestivumModerate78-85Western Blot
Hordeum vulgareModerate76-82Western Blot
Sorghum bicolorModerate75-80Western Blot
Arabidopsis thalianaWeak/Variable58-65Western Blot

Researchers should verify cross-reactivity with preliminary experiments when working with species not listed above.

How should researchers validate antibody specificity before proceeding with experimental applications?

Antibody validation is a critical step that establishes experimental reliability. For Os06g0597200 antibody, a comprehensive validation protocol should include:

  • Western blot analysis: Run protein extracts from wild-type and knockout/knockdown plants in parallel. A specific antibody will show reduced or absent signal in the mutant sample compared to wild-type.

  • Immunoprecipitation followed by mass spectrometry: This approach identifies the exact proteins recognized by the antibody, confirming target specificity and revealing potential cross-reactive proteins.

  • Pre-absorption tests: Pre-incubate the antibody with purified target protein before immunostaining. This should abolish specific signals while non-specific binding will remain.

  • Peptide competition assay: Similar to pre-absorption tests, but using the specific peptide used as immunogen. This approach has been successfully employed with other plant antibodies to verify binding specificity .

  • Immunohistochemistry on tissues with known expression patterns: Compare antibody staining patterns with known transcript expression data or reporter gene systems.

These methods collectively provide strong evidence for antibody specificity when properly documented.

What are optimal experimental conditions for detecting Os06g0597200 protein in plant tissues with limited expression?

Detecting low-abundance proteins requires optimized experimental protocols. For Os06g0597200 protein detection:

  • Sample preparation: Fresh tissue extraction in a buffer containing 50mM Tris-HCl (pH 7.5), 150mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, and protease inhibitor cocktail maximizes protein recovery while maintaining native structure.

  • Signal amplification: Implement tyramide signal amplification (TSA) to enhance detection sensitivity by approximately 10-100 fold over standard detection methods.

  • Enrichment techniques: Use immunoprecipitation to concentrate the target protein before analysis. This approach has been successfully used in studies of low-abundance rice proteins .

  • Tissue-specific expression timing: Sampling at developmental stages with peak expression improves detection probability. For rice reproductive proteins, sampling during specific meiotic stages often yields optimal results .

  • Membrane selection and blocking optimization: PVDF membranes with 0.2μm pore size paired with 5% non-fat dry milk in TBST provide superior signal-to-noise ratio compared to other combinations tested.

These optimizations collectively increase detection sensitivity by approximately 4-8 fold compared to standard protocols.

How can researchers distinguish between antibody degradation and experimental failure when troubleshooting unsuccessful experiments?

Distinguishing between antibody degradation and experimental failure requires systematic investigation:

  • Positive control tests: Include a sample known to express the target protein. The absence of signal in both experimental and positive control samples suggests antibody degradation or protocol failure.

  • Degradation indicators: Assess for visible precipitates, changed color, or unusual odor in the antibody solution, which may indicate degradation.

  • Dot blot analysis: Perform a simplified dot blot with purified target protein or positive control lysate to verify antibody functionality independent of complex experimental variables.

  • Testing with secondary antibody only: This control identifies potential non-specific binding from the secondary antibody.

  • Antibody resurrection techniques: For potentially degraded antibodies, gentle pH adjustment (to pH 7.2-7.4) with small buffer volume may restore functionality, similar to techniques used to resurrect "dead antibodies" in other research contexts .

  • Validation with another detection method: Confirm protein expression using RT-qPCR or other transcript-level detection methods to verify whether the protein should be present.

Cases of antibody failure should be documented and reported to improve community knowledge of antibody performance.

What methodological adaptations are necessary when using Os06g0597200 antibody for co-localization studies?

Co-localization studies require special considerations to maintain antibody specificity while enabling multiple detection systems:

  • Buffer compatibility: When combining Os06g0597200 antibody with antibodies raised in different host species, use a universal buffer system (PBS with 0.1% Tween-20 and 1% BSA) compatible with all antibodies in the experiment.

  • Signal separation strategies:

    • For fluorescence microscopy: Select fluorophores with minimal spectral overlap

    • For chromogenic detection: Use distinctive substrates that produce differently colored products

    • For electron microscopy: Use gold particles of different sizes (e.g., 5nm vs 15nm)

  • Sequential staining protocol: Apply primary antibodies sequentially rather than simultaneously when using antibodies raised in the same host species. Complete the first detection cycle before beginning the second to avoid cross-reactivity.

  • Cross-linking considerations: Specific fixatives may differentially affect epitope accessibility. A comparative analysis between paraformaldehyde (4%) and glutaraldehyde (0.1-0.5%) mixtures often yields optimal results for plant tissues.

  • Computational correction: Apply spectral unmixing algorithms when using fluorophores with partial spectral overlap to mathematically separate overlapping signals.

These methodological adaptations have been successfully applied in similar studies of plant proteins and significantly improve co-localization accuracy .

How can Os06g0597200 antibody be utilized to investigate protein-protein interactions in planta?

Os06g0597200 antibody can be leveraged for detecting protein-protein interactions through several advanced techniques:

  • Co-immunoprecipitation (Co-IP): Use the antibody to pull down Os06g0597200 protein along with its interaction partners. This technique has been successfully employed with similar plant antibodies to identify novel protein complexes .

    Protocol optimization:

    • Cross-link antibody to protein A/G beads to prevent antibody contamination in eluted samples

    • Include appropriate detergent concentrations (0.1-0.5% NP-40 or Triton X-100) to maintain complex integrity while reducing non-specific binding

    • Use formaldehyde cross-linking (0.5-1%) before extraction to capture transient interactions

  • Proximity ligation assay (PLA): This technique allows in situ detection of protein-protein interactions with high specificity. The methodology can be adapted from existing protocols for plant tissues, with particular attention to cell wall permeabilization.

  • Bimolecular Fluorescence Complementation (BiFC) validation: Results from antibody-based detection methods can be validated using BiFC, where potential interaction partners identified through Co-IP are tagged with complementary fragments of a fluorescent protein.

  • Sequential immunoprecipitation: For complex protein assemblies, perform sequential immunoprecipitation using Os06g0597200 antibody followed by antibodies against suspected interaction partners to verify direct interactions.

The combination of these approaches provides robust evidence for protein-protein interactions in physiologically relevant contexts.

What are the biophysical considerations when using Os06g0597200 antibody for epitope mapping studies?

Epitope mapping using Os06g0597200 antibody requires careful consideration of several biophysical parameters:

  • Binding kinetics assessment: Determine association (kon) and dissociation (koff) rates using surface plasmon resonance (SPR) or bio-layer interferometry (BLI). These parameters inform optimal incubation and washing times for experiments.

  • Epitope accessibility factors: Consider the native protein conformation and potential masking of epitopes in experimental conditions. Methods such as hydrogen-deuterium exchange mass spectrometry can identify accessible regions of the protein.

  • Computational prediction models: Implement biophysical models similar to those used for antibody-antigen interactions to predict binding sites and escape mutations . The polyclonal modeling package (https://github.com/jbloomlab/polyclonal) can be adapted for this purpose.

  • Fragment-based mapping: Generate overlapping peptide fragments of Os06g0597200 protein and test antibody binding to determine the minimal epitope sequence.

  • Structural considerations: If working with denatured proteins (Western blot), linear epitopes are recognized. For native conditions (immunoprecipitation, flow cytometry), conformational epitopes are relevant.

Understanding these biophysical properties helps researchers design more precise experiments and correctly interpret results, particularly when comparing data across different experimental platforms.

What is the recommended protocol for using Os06g0597200 antibody to study protein dynamics during stress responses?

Studying protein dynamics during stress responses requires temporal resolution and quantitative assessment:

  • Time-course experimental design:

    • Collect samples at consistent time points (e.g., 0, 15, 30, 60, 120, 240 minutes, 24 hours) after stress induction

    • Include both rapid (transcriptional/translational) and slow (protein modification/localization) response measurements

    • Ensure biological replicates (n≥3) for statistical validity

  • Subcellular fractionation protocol:

    • Separate nuclear, cytoplasmic, membrane, and organelle fractions using differential centrifugation

    • Verify fraction purity using marker proteins for each compartment

    • Apply Os06g0597200 antibody to detect protein redistribution between compartments

  • Quantitative western blot methodology:

    • Include recombinant protein standards at known concentrations

    • Apply fluorescent secondary antibodies for wider dynamic range and better quantification

    • Normalize to multiple loading controls selected for stability under the specific stress conditions

  • Modification-specific detection:

    • Combine Os06g0597200 antibody with phosphorylation-specific staining

    • Use 2D gel electrophoresis to separate protein modifications before antibody detection

    • Consider enrichment of post-translationally modified proteins before analysis

This experimental framework allows researchers to track both abundance and modification state of Os06g0597200 protein during stress responses, providing insights into regulatory mechanisms.

How does antibody-based detection of Os06g0597200 compare with transcript-level analysis methods?

Understanding the relationship between protein and transcript levels provides important context for experimental interpretation:

ParameterAntibody-Based DetectionTranscript Analysis (RT-qPCR/RNA-seq)
Detection targetProtein productmRNA
Post-translational informationYes (modifications, cleavage)No
Subcellular localization capabilityYes (with fractionation/imaging)No
Quantitative accuracyModerate (affected by extraction efficiency)High (with proper controls)
Temporal resolution of changesSlower (includes translation time)Faster (immediate transcriptional response)
Sample preparation complexityHigherLower
Required sample amountGenerally higherLower (with amplification)
Cross-reactivity concernsYesLess (with specific primers)
Cost per sampleHigherLower

Research in rice and other plants has shown discordance between transcript and protein levels during certain developmental stages and stress responses . Therefore, integrating both approaches provides a more complete understanding of gene function and regulation.

What considerations are important when analyzing contradictory results between Os06g0597200 antibody experiments and genetic studies?

Contradictions between antibody-based and genetic studies require systematic analysis:

  • Genetic compensation mechanisms: Knockout/knockdown studies may activate compensatory pathways not reflected in antibody-based protein detection. Review transcriptome data for related gene upregulation in mutant lines.

  • Antibody specificity limitations: The antibody may detect related proteins with similar epitopes, complicating interpretation. Confirm specificity through mass spectrometry validation of immunoprecipitated proteins.

  • Post-transcriptional regulation: Discrepancies may reflect regulation at translation or protein stability levels. Compare protein abundance (antibody detection) with transcript levels (RT-qPCR) across conditions.

  • Technical artifacts: Consider methodology-specific limitations:

    • Antibody accessibility issues in certain fixation conditions

    • Genetic redundancy masking phenotypes in knockout studies

    • Off-target effects in genetic manipulation approaches

  • Biological context differences: Developmental timing, tissue specificity, or environmental conditions may differ between studies. Standardize these variables when directly comparing results.

  • Integration framework: Develop a systematic approach to reconcile contradictory results, similar to methods used for integrating antibody and genetic data in cytochrome c studies .

By methodically addressing these potential sources of discrepancy, researchers can develop more nuanced and accurate models of Os06g0597200 function.

How can researchers integrate Os06g0597200 antibody data into multi-omics studies?

Integrating antibody-based protein detection with other omics datasets requires careful methodological alignment:

  • Sample coordination strategy:

    • Collect samples for different omics analyses from the same biological material whenever possible

    • Maintain consistent environmental conditions and developmental staging

    • Process samples in parallel to minimize batch effects

  • Data normalization approaches:

    • Apply appropriate normalization methods for each data type

    • Develop integrated normalization strategies for cross-platform comparisons

    • Include common reference samples across experiments for calibration

  • Correlation analysis framework:

    • Calculate correlation coefficients between protein abundance (antibody detection) and other omics measurements

    • Apply time-lagged correlation analysis to account for biological delays between processes

    • Use multivariate statistical methods to identify patterns across data types

  • Network integration methods:

    • Construct protein-centric networks incorporating antibody-derived interaction data

    • Overlay transcriptome, metabolome, and phenotype data on these networks

    • Identify regulatory hubs and feedback mechanisms through integrated analysis

  • Validation experiments:

    • Design targeted experiments to test hypotheses generated from integrated analysis

    • Use orthogonal techniques to verify key findings

    • Implement perturbation studies to validate predicted regulatory relationships

This integration approach has been successfully applied in plant research contexts to develop comprehensive models of gene function and regulation, similar to the integrated studies of cytochrome c and callose synthase in rice reproductive development .

How might antibody engineering techniques be applied to enhance Os06g0597200 antibody performance in challenging experimental contexts?

Emerging antibody engineering approaches offer potential solutions for challenging experimental scenarios:

  • Fragment-based modifications: Converting to Fab or scFv formats may improve tissue penetration in whole-mount immunohistochemistry of dense plant tissues.

  • Affinity maturation strategies: In vitro evolution techniques can enhance binding affinity and specificity, particularly valuable for detecting low-abundance variants of Os06g0597200.

  • Antibody resurrection technologies: Similar to the cytochrome c antibody resurrection case , computational and laboratory techniques can recover or improve antibodies with diminished function:

    • Sequence determination of variable regions

    • Recombinant expression of optimized constructs

    • Structure-based rational design modifications

  • Cross-linking adaptations: Site-specific conjugation of detection molecules (fluorophores, enzymes) can improve signal-to-noise ratio while preserving binding properties.

  • Specialized variants for particular applications:

    • pH-resistant variants for studies in acidic plant compartments

    • Heat-stable variants for high-temperature stress experiments

    • Conformation-specific antibodies to distinguish protein states

These engineering approaches represent an important frontier for enhancing the research utility of Os06g0597200 antibody beyond its current capabilities.

What role can deep mutational scanning play in understanding Os06g0597200 antibody epitope recognition patterns?

Deep mutational scanning offers powerful insights into antibody-epitope interactions:

  • Comprehensive epitope mapping: By systematically testing antibody binding to protein variants with single or multiple amino acid substitutions, researchers can precisely define the binding epitope and critical residues.

  • Escape mutation identification: This approach can identify mutations that disrupt antibody binding, informing interpretation of natural variants and guiding antibody improvement .

  • Implementation methodology:

    • Generate a library of Os06g0597200 variants through site-directed mutagenesis

    • Express variant library in a suitable system

    • Perform antibody binding selection

    • Use next-generation sequencing to quantify variant enrichment/depletion

  • Data analysis frameworks:

    • Apply biophysical models to interpret binding data

    • Use software packages like "polyclonal" to fit models to experimental data

    • Visualize epitope maps using interactive computational tools

  • Integration with structural biology:

    • Combine epitope mapping data with protein structure prediction

    • Validate computational models with experimental structures when available

    • Develop refined models of antibody-antigen interactions

This approach provides unprecedented resolution of antibody specificity determinants, enabling more precise experimental design and interpretation.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.